Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T Transmission in Day Care Children
NCT00192361Phase 3Completed
- Sponsor
- MedImmune
- Start
- Nov 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing CAIV-T with Placebo (2 arms). Primary endpoint: Proportion of placebo recipients from whom any of the vaccine strains were isolated. Started Nov 1999; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192361.